Home › Compare › WRCDF vs ABBV
WRCDF yields 666666.67% · ABBV yields 3.06%● Live data
📍 WRCDF pulled ahead of the other in Year 1
Combined, WRCDF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WRCDF + ABBV for your $10,000?
Wirecard AG, a technology company, provides outsourcing and white label solutions for electronic payments worldwide. The company operates in three segments: Payment Processing & Risk Management, Acquiring & Issuing, and Call Center & Communication Services. The Payment Processing & Risk Management segment offers products and service for the acceptance or transactions, and the processing of electronic payments and associated processes. The Acquiring & Issuing segment provides settlement services for credit card sales for online and terminal payments, as well as current accounts with prepaid cards and Girocard/Maestro debit cards; processes payment transactions in various currencies; and issues prepaid and debit cards to private and business customers. The Call Center & Communication Services segment offers value added services, aftersales services to customers, and mailing services. The company also provides payment processing solutions that include Wirecard Payment Page, a payment page; credit card processing; direct debit; online banking payment; alternative payment; international payment processing; tokenization; point of sale terminals; and Wirecard Checkout Portal, a payment portal. In addition, it offers mobile payment solutions; risk management solutions, such as fraud prevention, credit worthiness checks, and individual solutions; integration and testing solutions, including enterprise integration, transaction testing, payment hub, customer self-select PIN, and secure mailer solutions; and communication services. The company serves the consumer goods, digital goods, and travel and mobility sectors. Wirecard has strategic partnerships with Poynt, CreditPilot PLC, SunExpress, and Emonvia. Wirecard AG was founded in 1999 and is headquartered in Aschheim, Germany.
Full WRCDF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.